Fol. Biol. 2015, 61, 8-13

https://doi.org/10.14712/fb2015061010008

VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks

Vladimíra Ďurmanová1, I. Shawkatová1, J. Javor1, Z. Párnická1, D. Čopíková-Cudráková2, P. Turčáni2, I. Lisá3, B. Gajdošechová1, M. Buc1, M. Bucová1

1Institute of Immunology, School of Medicine, Comenius University in Bratislava, Slovakia
21st Department of Neurology, School of Medicine, Comenius University in Bratislava and University Hospital, Bratislava, Slovakia
32nd Department of Neurology, School of Medicine, Comenius University in Bratislava and University Hospital, Bratislava, Slovakia

Received June 2014
Accepted December 2014

References

1. Anaya, J. M., Kim-Howard, X., Prahalad, S., Cherñavsky, A., Cañas, C., Rojas-Villarraga, A., Bohnsack, J., Jonsson, R., Bolstad, A. I., Brun, J. G., Cobb, B., Moser, K. L., James, J. A., Harley, J. B., Nath, S. K. (2012) Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. Autoimmun. Rev. 11, 276-280. <https://doi.org/10.1016/j.autrev.2011.07.007>
2. Andreoli, V., Cittadella, R., Valentino, P., Condino, F., La Russa, A., Liguori, M., Manna, I., Spadafora, P., Nisticò, R., Pirritano, D., Clodomiro, A., Quattrone, A. (2007) The role of VLA4 polymorphisms in multiple sclerosis: an association study. J. Neuroimmunol. 189, 125-128. <https://doi.org/10.1016/j.jneuroim.2007.06.015>
3. Balnyte, R., Rastenyte, D., Vaitkus, A., Mickeviciene, D., Skrodeniene, E., Vitkauskiene, A., Uloziene, I. (2013). The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania. BMC Neuro. 13, 77. <https://doi.org/10.1186/1471-2377-13-77>
4. Benesova, Y., Vasku, A., Stourac, P., Hladikova, M., Fiala, A., Bednarik, J. (2013) Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis. J. Neuroimmunol. 255, 92-96. <https://doi.org/10.1016/j.jneuroim.2012.10.014>
5. Berlin, C., Bargatze, R. F., Campbell, J. J., von Andrian, U. H., Szabo, M. C., Hasslen, S. R., Nelson, R. D., Berg, E. L., Erlandsen, S. L., Butcher, E. C. (1995) α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80, 413-422. <https://doi.org/10.1016/0092-8674(95)90491-3>
6. Brum, D. G., Barreira, A. A., dos Santos, A. C., Kaimen- Maciel, D. R., Matiello, M., Costa, R. M., Deghaide, N. H., Costa, L. S., Louzada-Junior, P., Diniz, P. R., Comini- Frota, E. R., Mendes-Junior, C. T., Donadi, E. A. (2010) HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis. Mult. Scler. 16, 21-29. <https://doi.org/10.1177/1352458509350741>
7. Buc, M. (2013) Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis. Mediat. Inflamm. Article ID 963748, 11 pages. <https://doi.org/10.1155/2013/963748>
8. Correia, C., Coutinho, A. M., Almeida, J., Lontro, R., Lobo, C., Miguel, T. S., Martins, M., Gallagher, L., Conroy, J., Gill, M., Oliveira, G., Vicente, A. M. (2009) Association of the α4 integrin subunit gene (ITGA4) with autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 1147-1151. <https://doi.org/10.1002/ajmg.b.30940>
9. Goris, A., Walton, A., Ban, M., Dubois, B., Compston, A., Sawcer, S. (2008) A Taqman assay for high-throughput genotyping of the multiple sclerosis-associated HLADRB1* 1501 allele. Tissue Antigens 72, 401-403. <https://doi.org/10.1111/j.1399-0039.2008.01101.x>
10. Hafler, D. A., Compston, A., Sawcer, S., Lander, E. S., Daly, M. J., De Jager, P. L., de Bakker, P. I., Gabriel, S. B., Mirel, D. B., Ivinson, A. J., Pericak-Vance, M. A., Gregory, S. G., Rioux, J. D., McCauley, J. L., Haines, J. L., Barcellos, L. F., Cree, B., Oksenberg, J. R., Hauser, S. L. (2007) International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357, 851-862.
11. Heymann, G. A., Kiesewetter, H., Salama, A. (2003) Frequencies of α4 A3061G variants and identification of three new variants of the human integrin α4-subunit. Mol. Immunol. 39, 855-860. <https://doi.org/10.1016/S0161-5890(03)00009-9>
12. Hilger-Eversheim, K., Moser, M., Schorle, H., Buettner, R. (2000). Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 260, 1-12. <https://doi.org/10.1016/S0378-1119(00)00454-6>
13. Isobe, N., Gourraud, P. A., Harbo, H. F., Caillier, S. J., Santaniello, A., Khankhanian, P., Maiers, M., Spellman, S., Cereb, N., Yang, S., Pando, M. J., Piccio, L., Cross, A. H., De Jager, P. L., Cree, B. A., Hauser, S. L., Oksenberg, J. R. (2013). Genetic risk variants in African Americans with multiple sclerosis. Neurology 81, 219-227. <https://doi.org/10.1212/WNL.0b013e31829bfe2f>
14. Kurtzke, J. F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452. <https://doi.org/10.1212/WNL.33.11.1444>
15. Lambert, J. C., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., DeStafano A. L., Bis, J. C., Beecham, G. W., Grenier-Boley, B., Russo, G. et al. (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452-1458. <https://doi.org/10.1038/ng.2802>
16. Lincoln, M. R., Montpetit, A., Cader, M. Z., Saarela, J., Dyment, D. A., Tiislar, M., Ferretti, V., Tienari, P. J., Sadovnick, A. D., Peltonen, L., Ebers, G. C., Hudson, T. J. (2005) A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat. Genet. 37, 1108-1112. <https://doi.org/10.1038/ng1647>
17. Masterman, T., Ligers, A., Olsson, T., Andersson, M., Olerup, O., Hillert, J. (2000) HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann. Neurol. 48, 211-219. <https://doi.org/10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.0.CO;2-R>
18. Miller, S. A., Dykes, D. D., Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215. <https://doi.org/10.1093/nar/16.3.1215>
19. Nicot, A. (2009) Gender and sex hormones in multiple sclerosis pathology and therapy. Front. Biosci. (Landmark Ed.) 14, 4477-4515. <https://doi.org/10.2741/3543>
20. O’Connor, P., Miller, D., Riester, K., Yang, M., Panzara, M., Dalton, C., Miszkiel, K., Khan, O., Rice, G., Sheremata, W., International Natalizumab Trial Group (2005) Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis. Mult. Scler. 11, 568-572. <https://doi.org/10.1191/1352458505ms1205oa>
21. O’Connor, P. W., Goodman, A., Kappos, L., Lublin, F. D., Miller, D. H., Polman, C., Rudick, R. A., Aschenbach, W., Lucas, N. (2011) Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology 76, 1858-1865. <https://doi.org/10.1212/WNL.0b013e31821e7c8a>
22. O’Doherty, C., Roos, I. M., Antiguedad, A., Aransay, A. M., Hillert, J., Vandenbroeck, K. (2007) ITGA4 polymorphisms and susceptibility to multiple sclerosis. J. Neuroimmunol. 189, 151-157. <https://doi.org/10.1016/j.jneuroim.2007.07.006>
23. Patrucco, L., Larriba, J., Redal, M. A., Rojas, J. I., Argibay, P. F., Cristiano, E. (2009). HLA-DRB1 and multiple sclerosis in Argentina. Eur. J. Neurol. 16, 427–429. <https://doi.org/10.1111/j.1468-1331.2008.02523.x>
24. Pravica, V., Popadic, D., Savic, E., Markovic, M., Drulovic, J., Mostarica-Stojkovic, M. (2012) Single nucleotide polymorphisms in multiple sclerosis, disease susceptibility and treatment response biomarkers. Immunol. Res. 52, 42-52. <https://doi.org/10.1007/s12026-012-8273-y>
25. Sadovnick, A. D. (2012) Genetic background of multiple sclerosis. Autoimmun. Rev. 11, 163-166. <https://doi.org/10.1016/j.autrev.2011.05.007>
26. Schmidt, H., Williamson, D., Ashley-Koch, A. (2007) HLADR15 haplotype and multiple sclerosis: a HuGE review. Am. J. Epidemiol. 165, 1097-1109. <https://doi.org/10.1093/aje/kwk118>
27. Stankovich, J., Butzkueven, H., Marriott, M., Chapman, C., Tubridy, N., Tait, B. D., Varney, M. D., Taylor, B. V., Foote, S. J.; ANZgene Consortium, Kilpatrick, T. J., Rubio, J. P. (2009) HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens 74, 17-21. <https://doi.org/10.1111/j.1399-0039.2009.01262.x>
28. Szabo, M., McIntyre, B. W. (1995) Identification of two variants of the human integrin α4 subunit. Mol. Immunol. 32, 1453-1454. <https://doi.org/10.1016/0161-5890(96)00001-6>
29. Zivković, M., Stanković, A., Dincić, E., Popović, M., Popović, S., Raicević, R., Alavantić, D. (2009) The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective highthroughput detection by real-time PCR. Clin. Chim. Acta 406, 27-30. <https://doi.org/10.1016/j.cca.2009.05.004>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Archive